Blood cancers, Myeloma
Results
Phase 3
This trial looked at lenalidomide, carfilzomib, bortezomib and vorinostat for people having intensive treatment for newly diagnosed myeloma. It was supported by Cancer Research UK.
Recruitment start: 25 May 2010
Recruitment end: 24 February 2016
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Prof Graham Jackson
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Leeds
This is Cancer Research UK trial number CRUK/09/014.
Last reviewed: 27 Nov 2019
CRUK internal database number: 3350
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
